These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6755153)

  • 1. A selective medium for the isolation of the Acinetobacter genus bacteria.
    Zebral AA
    Mem Inst Oswaldo Cruz; 1980; 75(3-4):11-21. PubMed ID: 6755153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacteria of the genus Acinetobacter. Methods for their isolation and primary identification].
    Kalina GP
    Zh Mikrobiol Epidemiol Immunobiol; 1986 May; (5):15-21. PubMed ID: 3524077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of Acinetobacter sp. strains isolated from a hospital environment. III. Anitracinogenic properties of Acinetobacter calcoaceticus isolated from clinical specimens and other sources].
    Bugalski R; Gospodarek E; Gołuszko P
    Med Dosw Mikrobiol; 1988; 40(1):12-7. PubMed ID: 3210835
    [No Abstract]   [Full Text] [Related]  

  • 4. Acinetobacter infection.
    Kapoor R
    N Engl J Med; 2008 Jun; 358(26):2845-6; author reply 2846-7. PubMed ID: 18579824
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of neuraminidase in relation with biofilm formation among clinical and healthy skin isolates of Acinetobacter species.
    Prakasam G; Rohit A; Padmasini E; Ramesh SS
    Indian J Med Microbiol; 2014; 32(4):459-60. PubMed ID: 25297042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation of the L forms of Acinetobacter calcoaceticus var. Lwoffii in infectious endocarditis].
    Zubkov MN; Bogomolov BP; Gugutsidze EN; Lëvina GA
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):27-9. PubMed ID: 6380163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First isolation of Acinetobacter johnsonii co-producing PER-2 and OXA-58 β-lactamases.
    Rodríguez CH; Nastro M; Dabos L; Barberis C; Vay C; Famiglietti A
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):341-2. PubMed ID: 25294301
    [No Abstract]   [Full Text] [Related]  

  • 8. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.
    Akers KS; Barsoumian A; Beckius ML; Murray CK; Mende K
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):209-11. PubMed ID: 20466197
    [No Abstract]   [Full Text] [Related]  

  • 9. Siderophore production among clinical and healthy skin isolates of Acinetobacter species.
    Prakasam G; Rohit A; Kumar S; Ramesh SS
    Indian J Med Microbiol; 2013; 31(2):208-9. PubMed ID: 23867691
    [No Abstract]   [Full Text] [Related]  

  • 10. A note on the preparation and use of a selective differential medium for the isolation of Acinetobacter spp. from clinical sources.
    Holton J
    J Appl Bacteriol; 1983 Feb; 54(1):141-2. PubMed ID: 6853391
    [No Abstract]   [Full Text] [Related]  

  • 11. Environmental sampling of Acinetobacter baumannii: moistened swabs versus moistened sterile gauze pads.
    Corbella X; Pujol M; Argerich MJ; Ayats J; Sendra M; Peña C; Ariza J
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):458-60. PubMed ID: 10432154
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nonfermenting Gram-negative bacteria. III. Acinetobacter].
    Shenderov BA; Serkova GP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 May; (5):9-14. PubMed ID: 377870
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures.
    Maragakis LL; Tucker MG; Miller RG; Carroll KC; Perl TM
    JAMA; 2008 Jun; 299(21):2513-4. PubMed ID: 18523219
    [No Abstract]   [Full Text] [Related]  

  • 14. Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans.
    Nemec A; Musílek M; Maixnerová M; De Baere T; van der Reijden TJ; Vaneechoutte M; Dijkshoorn L
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):118-24. PubMed ID: 19126734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiological importance and identification of Acinetobacter in secondary and endogenous infections].
    Zubkova MN; Gnedoĭ SN
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):17-20. PubMed ID: 6868887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the Mima-Herellea group of organisms and selected members of the genus Neisseria.
    Marraro RV; Rheins MS
    Appl Microbiol; 1969 Oct; 18(4):575-8. PubMed ID: 5369297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of Leeds Acinetobacter Medium, a new selective and differential medium for isolation of clinically important Acinetobacter spp., and comparison with Herellea agar and Holton's agar.
    Jawad A; Hawkey PM; Heritage J; Snelling AM
    J Clin Microbiol; 1994 Oct; 32(10):2353-8. PubMed ID: 7814465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotyping of clinical isolates of Acinetobacter baumannii and genospecies 13 capable of growth at 44 degrees C: detection of four new serovars.
    Traub WH
    Zentralbl Bakteriol; 1998 Oct; 288(2):175-80. PubMed ID: 9809399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of strains of Acinetobacter spp. after culture in various media].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 2003 Apr; 52(2):72-5. PubMed ID: 12822537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of Acinetobacter spp. from food samples.
    Carvalheira A; Ferreira V; Silva J; Teixeira P
    Food Microbiol; 2016 May; 55():123-7. PubMed ID: 26742623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.